Enzyme Kinetics - 12th Bio-Chemistry MCQ with Answers
Unit 9 of 12th Bio-Chemistry explains how enzymes speed up reactions by lowering activation energy, derives the Michaelis-Menten and Lineweaver-Burk equations, defines Km, Vmax and turnover number, describes the lock and key and induced fit models, and compares competitive, noncompetitive, uncompetitive, allosteric and irreversible inhibition.
Study this chapter
Asked in previous board exams
6 questions from this chapter came in 3 past public exams. Open any of them to see the answer and explanation.
-
March 2026
ES complex formation is :See answer in the solved paper →
-
March 2026
Induced fit model was proposed by :See answer in the solved paper →
-
March 2025
A competitive inhibitor of an enzyme is usually __________.See answer in the solved paper →
-
March 2025
Lock and Key theory was proposed by __________.See answer in the solved paper →
-
March 2023
The number of molecules of substrate converted into product per enzyme molecule per second is called the __________.See answer in the solved paper →
-
March 2023
Induced fit model was proposed by __________.See answer in the solved paper →
About Enzyme Kinetics
Medium ~50 min study
Enzyme Kinetics is the ninth unit of the Tamil Nadu State Board Class 12 Bio-Chemistry book. It builds on the Class 11 idea of enzymes as biocatalysts and asks how fast an enzyme works and what slows it down.
The unit starts with specificity, activation energy and the effect of temperature, pH and concentration, then derives the Michaelis-Menten equation from four assumptions and turns it into the double reciprocal Lineweaver-Burk form. It goes on to the active site, Fischer's and Koshland's models, the evidence for the ES complex and the kinds of enzyme inhibition with their examples.
This page gathers the twenty book-back multiple choice questions of the Plus Two lesson with answers checked against the text, plus additional questions with short calculations of Km and Vmax and a short explanation for each.
What you'll learn
- Derive the Michaelis-Menten equation from its assumptions.
- Define Km and Vmax and state the significance of each.
- Obtain Km and Vmax from a Lineweaver-Burk plot.
- Compare the lock and key and induced fit models.
- Distinguish competitive, noncompetitive and uncompetitive inhibition.
- Give examples of allosteric and irreversible inhibition.
Before you start
- Enzymes as biocatalysts from Class 11 Bio-Chemistry.
- Proteins and amino acid side chains.
- The equation of a straight line, y = mx + c.
Topics covered in this chapter
Enzyme Kinetics explained
What this unit covers
Enzyme catalysis
Enzymes give a large rise in rate with high specificity. They lower the activation energy, a term coined by Arrhenius in 1889, but do not change the free energy change. Each enzyme has an optimum temperature and an optimum pH.
Michaelis-Menten kinetics
For E + S forming ES and then E + P, the steady-state assumption gives \( v = \frac{V_{max}[S]}{K_m + [S]} \), with \( K_m = \frac{k_2 + k_3}{k_1} \). The rate is first order at low [S], zero order at high [S], and half of \( V_{max} \) when [S] equals \( K_m \).
Lineweaver-Burk plot
Plotting 1/v against 1/[S] gives a straight line that cuts the Y axis at \( 1/V_{max} \) and the X axis at \( -1/K_m \), with slope \( K_m/V_{max} \). The turnover number is \( k_{cat} = V_{max}/[E_T] \).
Active site and models
The active site is a small three-dimensional cleft. Fischer's lock and key model treats it as rigid; Koshland's induced fit model, the more accepted one, lets it change shape.
Enzyme inhibition
Competitive inhibitors raise \( K_m \); noncompetitive inhibitors lower \( V_{max} \); uncompetitive inhibitors lower both. Allosteric enzymes give sigmoidal curves, and irreversible inhibitors such as nerve gases bind tightly.
Common mistakes to avoid
- Saying an enzyme changes the free energy change of a reaction. It only lowers the activation energy.
- Reading a high Km as strong binding. A high Km means weak binding.
- Mixing up the intercepts: the Y intercept is 1/Vmax and the X intercept is -1/Km.
- Thinking a competitive inhibitor lowers Vmax. It raises Km and leaves Vmax unchanged.
- Saying an uncompetitive inhibitor binds the free enzyme. It binds only the ES complex.
Test yourself on these with the practice test, then check the worked reasoning in the solved MCQs.
Frequently asked questions
What is Km?
Km, the Michaelis constant, is the substrate concentration at which the velocity is half of Vmax. It also equals (k2 + k3)/k1. It measures the strength of the ES complex: a high Km shows weak binding and a low Km strong binding. For most enzymes it lies between 10^-1 and 10^-7 M.
What assumptions are used to derive the Michaelis-Menten equation?
The enzyme concentration is much lower than the substrate concentration; the initial velocity is measured when [S] is far greater than [E]; none of the products revert to substrate; and a steady state is reached between the formation and breakdown of the ES complex.
How are Km and Vmax found from a Lineweaver-Burk plot?
The Lineweaver-Burk equation is the reciprocal of the Michaelis-Menten equation. A plot of 1/v against 1/[S] is a straight line. It cuts the Y axis at 1/Vmax and the X axis at -1/Km, and its slope is Km/Vmax, so both constants can be read off.
How does the induced fit model differ from the lock and key model?
Fischer's lock and key model treats the active site as a rigid lock into which the substrate fits like a key. Koshland's induced fit model says the first weak binding induces conformational changes in the enzyme that strengthen binding, so the active site is flexible. Induced fit is the more accepted model.
How do the three reversible inhibitors change Km and Vmax?
A competitive inhibitor resembles the substrate, binds the active site, raises Km and leaves Vmax unchanged. A noncompetitive inhibitor binds elsewhere, leaves Km unchanged and decreases Vmax. An uncompetitive inhibitor binds only the ES complex and decreases both Km and Vmax.
Why are sulpha drugs safe for humans?
Bacteria make folic acid from PABA, and sulphonamides are structural analogues of PABA, so they competitively block this synthesis and the bacteria die. Humans lack the enzymes for folic acid synthesis and obtain it as a vitamin in the diet, so the drug is nontoxic to human cells.
Last updated 27 October 2026